Van Dis E, Sogi KM, Rae CS, Sivick KE, Surh NH, Leong ML, Kanne DB, Metchette K, Leong JL, Bruml JR, Chen V, Heydari K, Cadieux N, Evans T, McWhirter SM, Dubensky TW, Portnoy DA, Stanley SA. STING-activating adjuvants elicit a Th17 immune response and protect against Mycobacterium tuberculosis infection.  Cell Reports, 2018. PMID: 29719256. 

Knight M, Braverman J, Asfaha K, Gronert K, Stanley SA. Lipid droplet formation in Mycobacterium tuberculosis infected macrophages requires IFN-γ/HIF-1α signaling and supports host defense. PLoS Pathogens, 2018. PMID 29370315

Braverman J, Stanley SA. Nitric oxide modulates macrophage responses to M. tuberculosis infection through activation of HIF-1α and repression of NF-kB.  J. Immunol, PMID 28754681.

Sogi KM, Lien KA, Johnson JR, Krogan NJ, Stanley SA. The tyrosine kinase inhibitor gefitinib restricts Mycobacterium tuberculosis growth through increased lysosomal biogenesis and modulation of cytokine signaling. ACS Infect Dis, 2017. PMID 28537707

Braverman J, Sogi KM, Benjamin D, Nomura DK, Stanley SA. HIF-1α is an essential mediator of IFN-γ dependent immunity to Mycobacterium tuberculosis. J. Immunol 2016. PMID 27430178.

Stanley, SA,  Barczak AK, Silvis, MR, Luo, SS,  Sogi, K, Vokes, M, Bray, M, Carpenter, AE, Siddiqi, N, Rubin EJ, Hung, DTH.  A chemical screen to identify host-targeted small molecules that restrict intracellular Mycobacterium tuberculosis growth. PLoS Pathog 2014 Feb; 10(2): e1003946. doi:10.1371/journal.ppat.1003946

Stanley, SA, Cox, JS.  Host-pathogen interactions during Mycobacterium tuberculosis infections.  Current topics in Microbiology and Immunology, 2013 July 24.

Kawate T, Iwase N, Shimuzu M, Stanley, SA, Kazyanskaya E, Hung D.  Synthesis and structure activity relationships of phenyl-substituted coumarins with anti-tubercular activity that target FadD32.  Biorganic and medicinal chemistry letters 2013 Nov 15; 23(22),6052-6059.

Grant SS, Kawate T, Nag PP, Silvis MR, Gordon K, Stanley, SA, Kazyanskaya E, Nietupski R, Golas A, Fitzgerald M, Cho S, Franzblau SG, Hung DT.  Identification of novel inhibitors of nonreplicating M. tuberculosis using a carbon starvation model.  ACS Chem Biol 2013 Aug 13; 8(10), 2224-2234.

Stanley, SA, Kawate, T, Iwase, N., Shimuzu, M, Clatworthy, A, Kazyanskaya, E, Siddiqi, N, Sacchettini JC, Ioerger TR, Aquadro, JA, Rubin, EJ, Hung, DTH. Diarylcoumarins inhibit mycolic acid biosynthesis and kill M. tuberculosis by targeting FadD32.  Proc Natl Acad Sci. 2013 Jul 9; 110(28):11565-70.

Stanley, SA, Kazyanskaya, E, Aquadro, JA, Silvis, M, Gomez, J, Hung, DT. Identification of novel inhibitors of M. tuberculosis growth using whole cell based high-throughput screening.  ACS Chem. Biol., 2012, 7(8), 1377–1384

Barczak, AK, Gomez, JE, Kaufmann, BB, Hinson, ER, Cosimi, L, Borowsky, ML, Onderdonk, AB, Stanley, SA, Kaur, D, Bryant, KF, Knipe, DM, Sloutsky, A, Hung, DT. RNA signatures allow rapid identification of pathogens and antibiotic susceptibilities.  Proc Natl Acad Sci USA, 2012 April 17; 109(16):6217-22.

Chindelevitch, L, Stanley, SA, Hung, D., Regev, A., Berger, B. MetaMerge: scaling up genome-scale metabolic reconstructions with application to Mycobacterium tuberculosis. Genome Biol. 2012 Jan 31; 13(1):R6.

Li X, Bolla K, Ashforth EJ, Zhuo Y, Gao H, Huang P, Stanley, SA, Hung DT, Zhang L. Systematic-guided bioprospecting for bioactive natural products.  Antonie van Leeuwenhoek 2012 101(1); 55-66.

McCahon, T.C., Stanley, SA, Kazyanskaya, E., Hung, D.T., Wood, J. A scalable formal total synthesis of dihydrogliotoxin.  Tetrahedron Lett. 2011 April; 52(17): 2262-2264.

Stanley, SA, Hung, DT. Chemical tools for dissecting bacterial physiology and virulence. Biochemistry, 2009 Sep. 22;48(37):8776-8610.  

Voehringer, D, Stanley, SA, Cox, JS, Completo, GC, Lowary, TL, Locksley, RM. Nippostrongylus brasiliensis: Identification of intelectin-1 and -2 as Stat6-dependent genes expressed in lung and intestine during infection. Exp. Parasitol. 2007 Aug;116(4):458-66.

Stanley, SA, Johndrow, JE, Cox, JS. The type I IFN response to infection with M. tuberculosis requires ESX-1 mediated secretion and contributes to pathogenicity. J. Immunol. 2007 Mar 1;178(5):3143-52.

Champion PA, Stanley, SA, Champion MM, Brown EJ, Cox JS. C-terminal signal sequence promotes virulence factor secretion in Mycobacterium tuberculosis. Science. 2006 Sep 15;313(5793):1632-6.

MacGurn, J.A., Raghavan, S., Stanley, SA, Cox, JS.  A non-RD1 gene cluster is required for Snm secretion in M. tuberculosis. Mol. Micro. 2005 Sep;57(6):1653-63.

Stanley, SA, Raghavan S, Hwang WW, Cox JS.  Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system.  Proc Natl Acad Sci USA. 2003 Oct 28;100(22):13001-6.